"Quintiles is excited about the progress made by PACeR toward speeding up clinical trials through more rapid patient recruitment and enrollment, and a reduced need for protocol amendments," said John Murphy, Head, Clinical Analytics in Consulting at Quintiles, and project manager for PACeR. "In addition to the benefit to patients of earlier access to innovative therapies, this could bring multi-million dollar savings to our biopharma customers as they work to respond to ever-changing conditions in the New Health, where managing risk is a constant."
New PACeR Participants Welcome
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
PACeR strongly encourages participation of additional members in Phase 2, and welcomes the perspectives of new members such as physician professional societies, community hospitals, device manufacturers, EMR vendors, disease societies, and others. The more comprehensive PACeR's membership, the more sustainable its approach becomes.Back to HCB News